a novel approach: tki/i-o combinations in rcc
Published 5 years ago • 102 plays • Length 3:15Download video MP4
Download video MP3
Similar videos
-
5:15
favorable-risk rcc: frontline vegf tki/io combinations
-
1:35
dr. grigg on immunotherapy/tki combinations in rcc
-
9:05
mrcc: when is tki/i-o combination therapy appropriate?
-
2:16
dr. amin on toxicities with immunotherapy/tki combinations in rcc
-
0:59
dr. alva on tki monotherapy and combinations for rcc
-
8:46
today immunotherapy can cure even fourth stage cancer: dr dattatreyudu nori
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
1:06:04
itp: novel treatments
-
2:07
dr. mcdermott on tki/immunotherapy combinations in rcc
-
1:40
dr. choueiri on checkpoint inhibitor/tki combinations in rcc
-
1:15
dr. figlin on toxicity profile of immunotherapy/vegf tki combinations in rcc
-
1:02
dr. mcdermott on novel immunotherapy combinations in rcc
-
7:36
novel approaches in advanced rcc
-
1:32
dr. figlin on promise of immunotherapy plus tki combinations in rcc
-
1:19
dr. beckermann on tki/immunotherapy combinations in mrcc
-
3:15
tki/i-o therapy in mrcc
-
3:01
potential immunotherapy combinations in rcc
-
6:45
the latest data on io/tki versus io/io in frontline rcc
-
1:06
promising tki-ici combinations for non-clear cell rcc
-
1:49
dr. mcgregor on new combinations with immunotherapy in rcc
-
1:15
michael b. atkins, md, on selecting i-o and tki combinations for the treatment of 1st line rcc
-
1:15
immunotherapy/tki combinations in advanced rcc